Dusan Perovic
Executive Officer · Deviation Co-Invest LLC - Deviate II
Exai Bio is a company focused on the early and accurate detection of cancer using a next-generation RNA-based platform. This platform delivers actionable insight into cancer biology from a simple blood draw. They utilize novel RNA biomarkers and AI to connect dots and find actionable clinical insights.
- Location: New York
- Status: unknown
Website
Fundraising guides
Browse all investors · Browse founders · Fundraising library